The mission of the Brain Barriers Research Center (BBRC) is to improve therapy delivery and treatments of brain disorders by fostering interdisciplinary brain barrier research.
The Chemical Biology Initiative (CBI) is designed to stimulate and encourage interdisciplinary biomedical/biotechnology research, technological development, and education at the cross roads of chemistry, physics, biology, and engineering at the University. Our central goal is to enable the development of a deeper understanding of biology that can be applied to the improvement of health.
The mission of the Center for Clinical and Cognitive Neuropharmacology is to promote interdisciplinary research investigating the interaction between individual patient characteristics and the effect of drugs on cognition. The work of the Center will guide new drug development and enhance the ability to personalize medication therapy.
The mission of the program is to generate, disseminate and apply knowledge about the causes, epidemiology, management and treatment of epilepsy and related seizure disorders. The program emphasizes research on antiepileptic drug clinical pharmacology, epidemiology and economics, practice models and outcomes including epilepsy surgery.
The Center for Forecasting Drug Response (CFDR) is a resource to researchers in the Department of Experimental and Clinical Pharmacology, the College of Pharmacy, the University of Minnesota and the community. There are three constituent divisions of the CFDR: Analytics, Pharmacometrics and Pharmacogenomics, each facilitated by an associated service.
The Center for Leading Healthcare Change offers leadership development for current pharmacy students, alumni and practicing pharmacists. The center provides a national platform for developing pharmacist leaders and for leading change in practice and policy.
The mission of the Center for Orphan Drug Research is to improve the care of individuals suffering from rare diseases through research on new therapies, education of health professionals and health profession students, and engagement in rare diseases/orphan drugs public policy.
A distinctive research group of investigators from various disciplines dedicated to advance the field of pharmacogenomics to help prescribe right medicine at the right dose and thus improve the safety and efficacy of currently prescribed medications.
The PRIME Institute is an independent and global research, education and consulting organization at the University whose mission is the study of the economic and policy issues to help improve popular access to pharmaceuticals and pharmaceutical services.
As an intercollegiate collaboration between the College of Pharmacy and the Medical School on the Duluth campus, RICH aims to provide an interdisciplinary center for research collaborations with Indigenous entities. RICH further aims to foster scholarly works that will identify health barriers and protective factors to increase healthcare equity for Indigenous patients.